Issues: Vax Specific

Anthrax

Hepatitis B

Hib

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

● 2010 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links

Search

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 

 

Catch-up Immunization Schedule
Ages 7 - 18 Years

UNITED STATES • 2009

 

 Vaccine
Min Age
for Dose 1
Minimum Interval Between Doses
Doses 1 and 2 Doses 2 and 3 Doses 3 and 4
Tetanus, Diphtheria/Diphtheria, Tetanus, Pertussis1
7 yrs1 4 wks 4 wks
if age at dose 1
< 12 mos

6 mos
if age at dose 1
≥ 12 mos

6 mos
if age at dose 1
< 12 mos
9 yrs             Routine dosing intervals are recommended
12 mos 6 mos    
Birth 4 wks 8 wks
and 16 wks after dose 1
 
6 wks 4 wks 4 wks 4 wksnote
12 mos 4 wks    
12 mos 4 wks
if age
≥ 13 yrs

3 mos
if age < 13 yrs

   

 

 
 

1. Tetanus and diphtheria toxoids vaccine (Td) and tetanus and diphtheria toxoids and acellular pertussis vaccine (Tdap).
• Tdap should be substituted for a single dose of Td in the primary catch-up series or as a booster if age appropriate; use Td for other doses.
• A 5-year interval from the last Td dose is encouraged when Tdap is used as a booster dose. A booster (fourth) dose is needed if any of the previous doses were administered at younger than 12 months of age. Refer to ACIP recommendations for further information.
See MMWR 2006;55(No. RR-3).

2. Human papillomavirus vaccine (HPV).
• Administer the HPV vaccine series to females at age 13–18 years if not previously vaccinated.

3. Hepatitis A vaccine (HepA).
• HepA is recommended for certain groups of children, including in areas where vaccination programs target older children. See MMWR 2006;55(No. RR-7):1–23.

4.Hepatitis B vaccine (HepB).
• Administer the 3-dose series to those who were not previously vaccinated.
• A 2-dose series of Recombivax HB® is licensed for children aged 11–15 years.

5. Inactivated poliovirus vaccine (IPV).
• For children who received an all-IPV or all-oral poliovirus (OPV) series, a fourth dose is not necessary if third dose was administered at age 4 years or older.
• If both OPV and IPV were administered as part of a series, a total of 4 doses should be administered, regardless of the child’s current age.
• IPV is not routinely recommended for persons aged 18 years and older.

6. Measles, mumps, and rubella vaccine (MMR).
• The second dose of MMR is recommended routinely at age 4–6 years but may be administered earlier if desired.
• If not previously vaccinated, administer 2 doses of MMR during any visit with 4 or more weeks between the doses.

7. Varicella vaccine.
• The second dose of varicella vaccine is recommended routinely at age 4–6 years but may be administered earlier if desired.
• Do not repeat the second dose in persons younger than 13 years of age if administered 28 or more days after the first dose.

 

This page was last updated on January 12, 2010